It might seem like sunshine, vacation and time spent with family and friends will bring you happiness this summer. But sometimes it takes a little more effort, said Lina Begdache, an associate professor of health and wellness studies at Binghamton University, State University of New York. If you’d like to lift your spirits, start by…  read on >  read on >

An experimental implant now under development could serve as a temporary monitor and pacemaker for ailing heart patients — then dissolve away when it’s no longer needed. The soft, lightweight and transparent implant is about the size of a postage stamp, and is made of polymers and metals that are biodegradable, researchers reported July 5…  read on >  read on >

American industry engages in some of the same high-risk practices as other countries in keeping and selling commercial animals that have the potential for triggering outbreaks of disease among humans, a new report shows. Researchers from Harvard Law School and New York University (NYU) studied this as part of a larger project in which they…  read on >  read on >

New federal initiatives could help save Americans money on health care costs. President Joe Biden announced plans Friday to target surprise medical bills, scam insurance and third-party credit cards and loans that carry high interest charges, the Associated Press reported. Limiting “junk” insurance plans is a key initiative. These are short-term policies that people sometimes…  read on >  read on >

Getting regular exercise can help protect against mental decline in an aging brain. But poor sleep can take away those benefits. A new study found that people who were more active but slept less than six hours on average had faster cognitive (mental) decline. After 10 years, their cognitive function was equivalent to that of…  read on >  read on >

The U.S. Food and Drug Administration on Thursday gave full approval to the Alzheimer’s drug Leqembi, clearing the way for insurance coverage of the pricey drug. “The full FDA approval will open the floodgates for people with early Alzheimer’s to get this drug. It’s a big deal because it’s very expensive at $26,500 per year,”…  read on >  read on >